Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

Estuary Biotherapeutics[ PART ]

A biotechnology company developing genetic medicines for patients with serious kidney diseases

Series A$93M~ 2025-05-3014

Company	Round	Amount	Announced	Role
Estuary Biotherapeutics A biotechnology company developing genetic medicines for patients with serious kidney diseases	Series A Verified against 1 of 14 sources	$93M	~ 2025-05-30	[ PART ]